Rare diseases
Investigational molecules
Locations
Back to Greece973 clinical trials in Athens, Greece across 13 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of IMVT-1402 Treatment for Adults with Graves' Disease
GreeceStudy of anifrolumab safety in adults with primary antiphospholipid syndrome (APS)
GreeceStudy of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease
GreeceStudy of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer's disease
GreeceStudy of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer's disease patients
GreeceStudy of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy
GreeceStudy of depemokimab to improve airway function in patients with type 2 eosinophilic asthma
GreeceStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
GreeceStudy of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
GreeceStudy comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer
GreeceStudy of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer
GreeceStudy of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis
GreeceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on head and neck cancer, bladder cancer, and advanced solid tumors. Research includes innovative combination therapies and novel treatment approaches for various tumor types.
Studies evaluate new therapeutic combinations and their impact on patient survival rates.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome, lupus, and inflammatory conditions.
Focus on developing targeted therapies for chronic autoimmune conditions.
Research examining treatments for heart failure, cardiovascular disease prevention, and metabolic disorders including obesity.
Trials evaluating new therapeutic approaches for cardiovascular risk reduction.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
